104411-14-5 Usage
Uses
Used in Hormone-Related Cancer Prevention:
<6,8,3',5'-2H4>equol is used as a preventive agent for reducing the risk of certain hormone-related cancers, such as breast, endometrial, and prostate cancers, due to its estrogenic effects.
Used in Menopause Management:
<6,8,3',5'-2H4>equol is used as a therapeutic agent for relieving menopausal symptoms, such as hot flashes and night sweats, by providing estrogenic effects.
Used in Osteoporosis Treatment:
<6,8,3',5'-2H4>equol is used as a potential treatment for osteoporosis, as it may help in maintaining bone density and reducing the risk of bone fractures.
Used in Cardiovascular Disease Management:
<6,8,3',5'-2H4>equol is used as a potential therapeutic agent for managing cardiovascular disease, possibly through its estrogenic effects on improving vascular health and reducing the risk of heart-related conditions.
Used in Pharmaceutical Industry:
<6,8,3',5'-2H4>equol is used as a compound in the pharmaceutical industry for the development of drugs targeting hormone-related conditions and diseases, leveraging its phytoestrogen properties.
Used in Nutritional Supplements:
<6,8,3',5'-2H4>equol is used as an ingredient in nutritional supplements, particularly for women experiencing menopause, to provide relief from menopausal symptoms and support overall health.
Check Digit Verification of cas no
The CAS Registry Mumber 104411-14-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,4,4,1 and 1 respectively; the second part has 2 digits, 1 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 104411-14:
(8*1)+(7*0)+(6*4)+(5*4)+(4*1)+(3*1)+(2*1)+(1*4)=65
65 % 10 = 5
So 104411-14-5 is a valid CAS Registry Number.
104411-14-5Relevant academic research and scientific papers
Synthesis of the -Labelled Urinary Lignans, Enterolactone and Enterodiol, and the Phytoestrogen Daidzein and its Metabolites Equol and O-Demethylangolensin
Waehaelae, Kristiina,Maekelae, Taru,Baeckstroem, Reijo,Brunow, Goeta,Hase, Tapio
, p. 95 - 98 (2007/10/02)
Methods are described for the synthesis of enterolactone, -trans-2,3-bis(3-hydroxybenzyl)-γ-butyrolactone>, enterodiol, -2,3-bis(3-hydroxybenzyl)butane-1,4-diol>, diadzein, -7-hydroxy-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-
